Our Leadership Team

At Exelixis, we believe that leadership happens at all levels across the company. We lead by example, fostering shared purpose and a heartfelt passion for giving patients hope as the core driver of business performance. Together, we are resilient in the face of adversity, relentless in delivering results and unwavering in our commitment to excel for patients through the work we do and medicines we bring to market. We strive to create sustained value by translating science and opportunity into impact.

Michael M. Morrissey, Ph.D.
Michael M. Morrissey, Ph.D.

President and Chief Executive Officer

Vicki L. Goodman, M.D.
Vicki L. Goodman, M.D.

Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer

Dana T. Aftab, Ph.D.
Dana T. Aftab, Ph.D.

Executive Vice President, Discovery and Translational Research and Chief Scientific Officer

Christopher J. Senner
Christopher J. Senner

Executive Vice President and Chief Financial Officer

Laura Dillard
Laura Dillard

Executive Vice President, Human Resources

P.J. Haley
P.J. Haley

Executive Vice President, Commercial

Jeffrey J. Hessekiel, J.D.
Jeffrey J. Hessekiel, J.D.

Executive Vice President, General Counsel and Secretary

Susan T. Hubbard
Susan T. Hubbard

Executive Vice President, Public Affairs and Investor Relations

Peter Lamb, Ph.D.
Peter Lamb, Ph.D.

Executive Vice President, Scientific Strategy

Our Board of Directors

Our Board of Directors represent significant expertise in fields of biotechnology, pharmaceuticals, clinical medicine and healthcare policy.